Author:
Schrag Anette,Quinn Niall
Publisher
Oxford University Press (OUP)
Reference45 articles.
1. Arai N, Isaji M, Kojima M, Mizuta E, Kuno S. Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys. J Neural Transm1996; 103: 1307–16.
2. Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology1985; 35: 949–56.
3. Barbeau A. High-level levodopa therapy in severely akinetic parkinsonian patients: twelve years later. In: Rinne UK, Klinger M, Stammer G. Parkinson's disease: current progress, problems and management. Amsterdam: Elsevier; 1980. p. 229–39.
4. Blin J, Bonnet AM, Agid Y. Does levodopa aggravate Parkinson's disease? Neurology1988; 38: 1410–6.
5. Block G, Liss C, Reines S, Irr J, Nibbelink D. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Eur Neurol1997; 37: 23–7.
Cited by
502 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献